Detalhe da pesquisa
1.
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.
Liver Int
; 41(4): 692-704, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387381
2.
Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals.
J Gen Intern Med
; 35(4): 1011-1020, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659661
3.
Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.
J Hepatol
; 71(3): 486-497, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31096006
4.
Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
J Hepatol
; 72(3): 592-593, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31889556
5.
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.
PLoS One
; 13(8): e0196908, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30067745
6.
Sensibilidad y especificidad de indicadores antropométricos de adiposidad y distribución de grasa en niños y adolescentes Venezolanos / Sensitivity and specificity of anthropometric indicators of adiposity and fat distribution in Venezuelan children and adolescents / Sensibilidade e especificidade de indicadores antropométricos de adiposidade e distribuição de gordura em crianças e adolescentes Venezuelanos
Interciencia
; 34(2): 84-90, feb. 2009. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-630759